Chiron Capital Management’s Medtronic MDT Stock Holding History

Chiron Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$768K	Buy	9,821 +5,075	+107%	+$409K	0.69%	45
2026 Q1	$411K	Buy	+4,746	New	+$455K	0.42%	64
2025 Q3	$942K	Sell	9,895 -4,652	-32%	-$428K	0.81%	38
2025 Q2	$1.27M	Buy	14,547 +1,296	+10%	+$110K	1.1%	27
2025 Q1	$1.19M	Sell	13,251 -6,601	-33%	-$591K	1.08%	24
2024 Q4	$1.59M	Buy	19,852 +3,447	+21%	+$298K	1.5%	12
2024 Q3	$1.48M	Sell	16,405 -4,382	-21%	-$369K	1.31%	16
2024 Q2	$1.64M	Buy	20,787 +3,167	+18%	+$260K	1.56%	12
2024 Q1	$1.54M	Buy	17,620 +318	+2%	+$27.1K	1.39%	12
2023 Q4	$1.43M	Buy	17,302 +3,002	+21%	+$229K	1.24%	18
2023 Q3	$1.12M	Buy	14,300 +9,100	+175%	+$762K	0.96%	26
2023 Q2	$458K	Sell	5,200 -3,900	-43%	-$336K	0.36%	60
2023 Q1	$734K	Buy	9,100 +400	+5%	+$32.6K	0.51%	45
2022 Q4	$676K	Buy	8,700 +3,500	+67%	+$284K	0.47%	45
2022 Q3	$420K	Buy	+5,200	New	+$467K	0.28%	72

Other funds holding MDT

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Chiron Capital Management's MDT Position: Q2 2026 in Review

Chiron Capital Management increased its Medtronic (MDT) stake by 107% in Q2 2026, buying an estimated $409K and bringing the position to 9,821 shares worth $768K. The position accounts for 0.69% of the portfolio, ranked #45.

Chiron Capital Management first reported a position in MDT in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.64M in Q2 2024. 638 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Chiron Capital Management held 9,821 shares of Medtronic worth $768K as of Q2 2026.
Chiron Capital Management bought 5,075 Medtronic shares in Q2 2026, an estimated $409K.
Medtronic made up 0.69% of Chiron Capital Management's portfolio in Q2 2026, its #45 holding.
Chiron Capital Management first reported a position in Medtronic in Q3 2022 and has held it in 15 quarters since.
Chiron Capital Management's Medtronic position peaked at $1.64M in Q2 2024.
638 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.